Reaction

T-Cell Lymphoma Refractory reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 35 reports · 3 co-occurring drugs

As of the last recalculation, T-Cell Lymphoma Refractory appears in 35 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is IFOSFAMIDE (PRR 2,419.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ifosfamide252,419.42,422.2
Mesna Injection111,154.01,155.6
Mesna111,132.71,134.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.